Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Risk Factor Analysis of Outcomes after Unrelated Cord Blood Transplantation for Children with Hurler’s Syndrome. An Eurocord-Duke University Collaborative Study.

Jaap Jan Boelens, MD, PhD, Vanderson Rocha, MD, Mieke Aldenhoven, MD, Robert Wynn, MD, Anne O’Meara, MD, Marina Cavazzana-Calvo, MD PhD, Irina Ionescu, MD, Suhag Parikh, MD, Vinod Prasad, MD, Maria Escolar, MD, Eliane Gluckman, MD PhD, Joanne Kurtzberg, MD

Blood (2007) 110 (11): 5076.

https://doi.org/10.1182/blood.V110.11.5076.5076

Published: 2007

Journal Articles

Acute Graft Versus Host Disease (GVHD) Is Increased in Patients Receiving Cyclosporine/Cellcept as Frontline Prophylaxis Against GVHD in Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation.

Sonali Lakshminarayanan, MD, Paul Szabolcs, MD, Vinod Prasad, MD, Suhag Parikh, MD, Susan Wood, MSN,PNP, Gilbert Ciocci, MSN,FNP, Lauren Stafford, MSN,PNP, Lynn Boyd, RN, Timothy Driscoll, MD, Paul L. Martin, MD,PhD, Joanne Kurtzberg, MD

Blood (2006) 108 (11): 2896.

https://doi.org/10.1182/blood.V108.11.2896.2896

Published: 2006

Journal Articles

The Addition of Fludarabine to a Conventional Busulfan/Melphalan/Anti-Thymocyte Globulin (Flu/Bu/Mel/ATG) Preparative Regimen Increased Engraftment without Additional Toxicity.

Sonali Lakshminarayanan, MD, Adam Mendizabal, Vinod Prasad, MD, Suhag Parikh, MD, Paul Szabolcs, MD, Timothy Driscoll, MD, Michelle Schweitzer, MSN,PNP, Barbara Kassmann, MSN,PNP, Mary Paden, MSN,PNP, Danielle Robinette, RN, Paul L. Martin, MD, Phd, Joanne Kurtzberg, MD

Blood (2006) 108 (11): 2944.

https://doi.org/10.1182/blood.V108.11.2944.2944

Published: 2006

Journal Articles

Unique Reversible but Serious Adverse Events in Very Young Infants Undergoing Unrelated Donor Umbilical Cord Blood Transplantation for Non-Malignant Conditions: Increased Autoimmune Cytopenias and Hypertrophic Cardiomyopathy.

Sonali Lakshminarayanan, MD, Paul Szabolcs, MD, Suhag Parikh, MD, Susan J. Wood, MN, CPNP, June Allison, RN, CPON, Joanne Kurtzberg, MD

Blood (2005) 106 (11): 5456.

https://doi.org/10.1182/blood.V106.11.5456.5456

Published: 2005

Journal Articles

Transplant Outcomes and Stabilization of Neurological Function in Young Children with MPS III (Sanfilippo Syndrome) after Unrelated Donor Umbilical Cord Blood Transplantation.

Sonali Lakshminarayanan, MD, Paul Szabolcs, MD, Vinod K. Prasad, MD, MRCP, Suhag Parikh, MD, June Allison, RN, CPON, Susan J. Wood, MN, CPNP, Maria Escolar, MD, Joanne Kurtzberg, MD

Blood (2005) 106 (11): 2050.

https://doi.org/10.1182/blood.V106.11.2050.2050

Published: 2005

NARROW

Risk Factor Analysis of Outcomes after Unrelated Cord Blood Transplantation for Children with Hurler’s Syndrome. An Eurocord-Duke University Collaborative Study.

Acute Graft Versus Host Disease (GVHD) Is Increased in Patients Receiving Cyclosporine/Cellcept as Frontline Prophylaxis Against GVHD in Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation.

The Addition of Fludarabine to a Conventional Busulfan/Melphalan/Anti-Thymocyte Globulin (Flu/Bu/Mel/ATG) Preparative Regimen Increased Engraftment without Additional Toxicity.

Unique Reversible but Serious Adverse Events in Very Young Infants Undergoing Unrelated Donor Umbilical Cord Blood Transplantation for Non-Malignant Conditions: Increased Autoimmune Cytopenias and Hypertrophic Cardiomyopathy.

Transplant Outcomes and Stabilization of Neurological Function in Young Children with MPS III (Sanfilippo Syndrome) after Unrelated Donor Umbilical Cord Blood Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Risk Factor Analysis of Outcomes after Unrelated Cord Blood Transplantation for Children with Hurler’s Syndrome. An Eurocord-Duke University Collaborative Study.

Acute Graft Versus Host Disease (GVHD) Is Increased in Patients Receiving Cyclosporine/Cellcept as Frontline Prophylaxis Against GVHD in Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation.

The Addition of Fludarabine to a Conventional Busulfan/Melphalan/Anti-Thymocyte Globulin (Flu/Bu/Mel/ATG) Preparative Regimen Increased Engraftment without Additional Toxicity.

Unique Reversible but Serious Adverse Events in Very Young Infants Undergoing Unrelated Donor Umbilical Cord Blood Transplantation for Non-Malignant Conditions: Increased Autoimmune Cytopenias and Hypertrophic Cardiomyopathy.

Transplant Outcomes and Stabilization of Neurological Function in Young Children with MPS III (Sanfilippo Syndrome) after Unrelated Donor Umbilical Cord Blood Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only